Skip to main content
. 2021 Jul 28;69(10):2973–2984. doi: 10.1111/jgs.17375

TABLE 2.

Summary of participant and study characteristics of the 220 randomized controlled trials (n = 104,638) identified in our original search

Participant and study characteristics Number of studies (%)
Mean age (years)
65–74 68 (30.9)
75–84 128 (58.2)
≥85 11 (5.0)
Not reported 13 (5.9)
Female (%)
0–49 18 (8.2)
50–100 198 (90.0)
Not reported 4 (1.8)
History of falls in the last 12 months
Fallers only 33 (15.0)
Mixed 103 (46.8)
Non‐fallers only 0
Not reported 84 (38.2)
Year of publication
1990–2002 36 (16.4)
2003–2007 45 (20.5)
2008–2012 54 (24.5)
2013–2017 67 (30.5)
2018–2019 18 (8.2)
Continent
Europe 87 (39.5)
Australia/New Zealand 49 (22.3)
North America 48 (21.8)
Asia 29 (13.2)
South America 5 (2.3)
Multicontinent 2 (0.9)
Study design
Parallel 192 (87.3)
Cluster 27 (12.3)
Both 1 (0.5)
Site
Multicenter 91 (41.4)
Single center 129 (58.6)
Sample size
<100 54 (24.5)
100–299 78 (35.5)
300–999 71 (32.3)
≥1000 17 (7.7)
Duration of intervention (weeks)
0–26 114 (51.8)
27–52 53 (24.1)
≥52 32 (14.5)
Not reported 21 (9.6)
Duration of follow‐up (weeks)
0–26 62 (28.2)
27–52 111 (50.5)
≥52 46 (20.9)
Not available/reported 1 (0.5)
Number of components
Single intervention 99 (45.0)
Multiple intervention a 75 (34.1)
Multifactorial intervention b 46 (20.9)
a

Participants received the same, fixed combination of two or more types of interventions.

b

Participants received a combination of two or more types of interventions, which were personalized according to the results of a pre‐executed falls risk assessment.